MeiraGTx Holdings (MGTX) Revenue (2019 - 2025)
MeiraGTx Holdings (MGTX) reported Revenue of $75.4 million for Q4 2025, up 252.33% on a YoY basis from $21.4 million in Q4 2024, and up 18281.46% quarter-over-quarter from $410000.0 in Q3 2025.
MeiraGTx Holdings (MGTX) Revenue (2019 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Revenue for 7 years, with the latest figure at $75.4 million in Q4 2025.
- For the quarter ending Q4 2025, Revenue rose 252.33% year-over-year to $75.4 million; the trailing twelve-month figure through Dec 2025 stood at $100.9 million (up 203.06% YoY), and the FY2025 full-year result was $81.4 million, up 144.57% from the prior year.
- Revenue for Q4 2025 stood at $75.4 million, up from $410000.0 in the prior quarter.
- The five-year high for Revenue was $75.4 million in Q4 2025, with the low at -$5.3 million in Q4 2022.
- Historically, Revenue has averaged $9.5 million across 5 years, with a median of $4.8 million in 2022.
- Annual changes were most pronounced in 2022 — Revenue plunged 125.13% — and 2025, when it soared 1208.87%.
- MeiraGTx Holdings' Revenue stood at $21.0 million in 2021, then sank by 125.13% to -$5.3 million in 2022, then soared by 138.58% to $2.0 million in 2023, then jumped by 948.53% to $21.4 million in 2024, then jumped by 252.33% to $75.4 million in 2025.
- The last three Revenue figures came in at $75.4 million (Q4 2025), $410000.0 (Q3 2025), and $3.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | MeiraGTx Holdings | 772.13 Mn | 706.20 Mn | 74.89 Mn | 75.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75.36 Mn |
| Sep 30, 2025 | 410,000.00 |
| Jun 30, 2025 | 3.69 Mn |
| Dec 31, 2024 | 21.39 Mn |
| Sep 30, 2024 | 10.91 Mn |
| Jun 30, 2024 | 282,000.00 |
| Mar 31, 2024 | 697,000.00 |
| Dec 31, 2023 | 2.04 Mn |
| Sep 30, 2023 | 5.10 Mn |
| Jun 30, 2023 | 3.54 Mn |
| Mar 31, 2023 | 3.33 Mn |
| Dec 31, 2022 | -5.29 Mn |
| Sep 30, 2022 | 4.82 Mn |
| Jun 30, 2022 | 10.76 Mn |
| Mar 31, 2022 | 5.63 Mn |
| Dec 31, 2021 | 21.04 Mn |
| Sep 30, 2021 | 6.95 Mn |
| Jun 30, 2021 | 5.12 Mn |
| Mar 31, 2021 | 4.60 Mn |
| Dec 31, 2020 | 3.79 Mn |